GPR43: an emerging target for the potential treatment of type 2 diabetes, obesity and insulin resistance.
Tiwari
Atul
A
Jubilant Biosys Ltd, Drug Discovery Unit, Metabolic Disorder Lab, 96, 2nd Stage, Industrial Suburb, Yeshwantpur, Bangalore, Karnatka, 560022, India. atul_tiwari@jubilantbiosys.com